Detalhe da pesquisa
1.
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.
Lancet
; 396(10265): 1817-1828, 2020 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33278935
2.
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial.
Breast Cancer Res
; 22(1): 124, 2020 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33176887
3.
Tumor-infiltrating lymphocytes in Breast Cancer and implications for clinical practice.
Biochim Biophys Acta Rev Cancer
; 1868(2): 527-537, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061314
4.
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
N Engl J Med
; 373(2): 123-35, 2015 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26028407
5.
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
N Engl J Med
; 373(17): 1627-39, 2015 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26412456
6.
Feasibility and Acute Toxicity of Hypo-Fractionated Radiotherapy on 0.35T MR-LINAC: The First Prospective Study in Spain.
Cancers (Basel)
; 16(9)2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38730637
7.
Influencing cancer treatment.
Lancet Oncol
; 16(16): 1591-3, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26678188
8.
Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study.
Cancers (Basel)
; 13(21)2021 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771596
9.
Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design.
Contemp Clin Trials Commun
; 20: 100678, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33336109
10.
High Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features.
Cancers (Basel)
; 11(1)2019 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30641862
11.
Tumor-Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy.
J Natl Cancer Inst
; 111(1): 69-77, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29788230
12.
Surgical resection of a solitary pancreatic metastasis from colorectal cancer: a new step to a cure?
Clin Colorectal Cancer
; 7(6): 398-401, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19036693
13.
Is there a role for immunotherapy in HER2-positive breast cancer?
NPJ Breast Cancer
; 4: 21, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30131972
14.
Role of tyrosine kinase inhibitors in the treatment of advanced colorectal cancer.
Clin Colorectal Cancer
; 6(10): 691-9, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18039422
15.
The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies.
Cancer Treat Rev
; 61: 53-60, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29100169
16.
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).
J Clin Oncol
; 35(35): 3924-3933, 2017 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29023213
17.
CXCR4 antagonists for treatment of breast cancer.
Oncotarget
; 9(71): 33442-33443, 2018 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323888
18.
An unusual metastatic renal cell carcinoma with maintained complete response to sunitinib treatment.
Case Rep Oncol
; 4(3): 583-6, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22220154